Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other biologically active molecules. Its structure, featuring a 2,6-difluorophenyl group, supports the formation of peptide-like chains with high stereochemical control, making it valuable in drug design where enantiomeric purity is critical. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) for antiviral and anticancer agents. The Boc-protected amine and carboxylic acid functionalities allow for selective and stepwise coupling reactions in multi-step organic syntheses.